Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Coller Capital raises $17bn as secondaries cement core role in portfolios
Coller Capital raises $17bn as secondaries cement core role in portfolios Coller Capital has raised $17bn for its global private equity secondaries platform, underlining the rapid institutionalisation of secondaries as a core portfolio allocation. The fundraising...
Ares raises $7.1bn for credit secondaries in largest inaugural fundraise
Ares raises $7.1bn for credit secondaries in largest inaugural fundraise Ares Management has raised approximately $7.1bn for its Credit Secondaries strategy, including the final closing of its inaugural Ares Credit Secondaries Fund and affiliated vehicles. The...
CVC-backed Global Sport Group launches €2.7bn debt raise to fund sports dealmaking
CVC-backed Global Sport Group launches €2.7bn debt raise to fund sports dealmaking Global Sport Group, the sports investment vehicle owned by CVC Capital Partners, has kicked off a €2.7bn debt-raising process aimed at financing further acquisitions across global...